Anesthesia General
📧 Sign up to get email alerts when something new happens for Anesthesia General.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Influence of Sevoflurane and Propofol on Maximum Muscular Strength, Speed of Contraction and Relaxation [Phase 3]
Phase 3 clinical trial evaluating how sevoflurane and propofol affect maximum muscular strength, contraction speed, and relaxation.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR [Phase 4]
A Phase 4 trial update evaluating the efficacy and safety of ciprofol compared to propofol for nonintubated general anesthesia in patients u…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026) [Phase 3]
Phase 3 clinical trial comparing recovery from rocuronium followed by sugammadex versus succinylcholine for anesthesia recovery; results pos…
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023) [Phase 3]
A Phase 3 trial evaluating the use of sugammadex at the end of general anesthesia shows completed results as of 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Japanese Participants. Part A (P05957) [Phase 2]
Phase 2 bridging trial evaluating Sugammadex (Org 25969) at 1-2 post-tetanic count in Japanese participants; completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part A: Japanese Participants (P05956) [Phase 2]
A Phase 2 bridging trial comparing Sugammadex (Org 25969) at reappearance of T2 in Japanese vs Caucasian participants (Part A: Japanese Part…